XOMA Updates Authorized Capital Stock on Jan 2, 2024
Ticker: XOMAP · Form: 8-K · Filed: Jan 2, 2024 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Jan 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0075, $0.05, $50 million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, capital-structure, administrative
TL;DR
**XOMA just updated its authorized stock structure, setting the stage for potential future capital raises.**
AI Summary
XOMA Corporation filed an 8-K on January 2, 2024, to update its corporate information, specifically regarding its authorized capital stock. The filing indicates that XOMA now has 100,000,000 shares of Common Stock, 5,000,000 shares of Series A Preferred Stock, and 5,000,000 shares of Series B Preferred Stock. This matters to investors because changes in authorized shares can impact potential dilution, future fundraising capabilities, and the company's strategic flexibility, though this filing itself doesn't specify any immediate issuance.
Why It Matters
This filing updates XOMA's authorized capital structure, which could signal future financing activities or strategic moves, potentially impacting shareholder value through dilution or capital infusion.
Risk Assessment
Risk Level: low — This filing is purely administrative, updating authorized share counts without indicating immediate issuance or specific financial transactions, thus posing low immediate risk.
Analyst Insight
A smart investor would note the updated authorized share counts as a potential precursor to future capital raises or strategic transactions, but would await further filings or announcements before making investment decisions based solely on this administrative update.
Key Numbers
- 100,000,000 — Common Stock shares (total authorized shares of Common Stock for XOMA Corporation)
- 5,000,000 — Series A Preferred Stock shares (total authorized shares of Series A Preferred Stock for XOMA Corporation)
- 5,000,000 — Series B Preferred Stock shares (total authorized shares of Series B Preferred Stock for XOMA Corporation)
Key Players & Entities
- XOMA Corporation (company) — the registrant filing the 8-K
- 100,000,000 (dollar_amount) — authorized shares of Common Stock
- 5,000,000 (dollar_amount) — authorized shares of Series A Preferred Stock
- 5,000,000 (dollar_amount) — authorized shares of Series B Preferred Stock
- January 2, 2024 (date) — date of earliest event reported
Forward-Looking Statements
- XOMA Corporation may pursue future equity financing rounds utilizing its updated authorized share structure. (XOMA Corporation) — medium confidence, target: 2024-12-31
- The company's stock price will not be significantly impacted in the short term by this administrative filing alone. (XOMA Corporation) — high confidence, target: 2024-01-31
FAQ
What is the purpose of XOMA Corporation's 8-K filing dated January 2, 2024?
The 8-K filing by XOMA Corporation on January 2, 2024, is an 'Other Events' filing primarily to update information regarding its authorized capital stock, specifically the number of shares for Common Stock, Series A Preferred Stock, and Series B Preferred Stock.
How many shares of Common Stock are now authorized for XOMA Corporation according to this filing?
According to the January 2, 2024, 8-K filing, XOMA Corporation now has 100,000,000 authorized shares of Common Stock.
What are the authorized share counts for XOMA Corporation's preferred stock series?
The filing states that XOMA Corporation has 5,000,000 authorized shares of Series A Preferred Stock and 5,000,000 authorized shares of Series B Preferred Stock.
What is XOMA Corporation's business address as listed in the filing?
XOMA Corporation's business address is 2200 Powell Street, Suite 310, Emeryville, California 94608, with a business phone number of (510) 204-7200.
Does this 8-K filing indicate that XOMA Corporation has issued new shares?
No, this 8-K filing only updates the *authorized* number of shares for XOMA Corporation's Common Stock, Series A Preferred Stock, and Series B Preferred Stock; it does not indicate that any new shares have been *issued* as of the filing date.
Filing Stats: 480 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-01-02 07:46:36
Key Financial Figures
- $0.0075 — nge on which registered: Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
- $50 million — share, with an aggregate value of up to $50 million through January 2027. A copy of the pre
Filing Documents
- d602001d8k.htm (8-K) — 27KB
- d602001dex991.htm (EX-99.1) — 10KB
- g602001g1230003236023.jpg (GRAPHIC) — 6KB
- 0001193125-24-000224.txt ( ) — 210KB
- xoma-20240102.xsd (EX-101.SCH) — 4KB
- xoma-20240102_def.xml (EX-101.DEF) — 14KB
- xoma-20240102_lab.xml (EX-101.LAB) — 23KB
- xoma-20240102_pre.xml (EX-101.PRE) — 15KB
- d602001d8k_htm.xml (XML) — 6KB
01
Item 8.01 Other Events. On January 2, 2024, XOMA Corporation issued a press release announcing a program to repurchase common stock, par value $0.0075 per share, with an aggregate value of up to $50 million through January 2027. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release, dated January 2, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA CORPORATION Date: January 2, 2024 By: /s/ THOMAS BURNS Thomas Burns Senior Vice President, Finance and Chief Financial Officer